CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Instagram Outage Disrupts Thousands of U.S. Users 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
WASHINGTON, March 06, 2017 -- Surefire Medical, Inc. today announced the launch of the new Flexion Guiding Catheter at the Society for Interventional Radiology (SIR) meeting in Washington, DC. The device has a main curve reinforced with nitinol to provide better shape retention and back-up support for interventional radiologists performing embolization procedures.
In addition to the differentiated nitinol curve, the Surefire Flexion offers the following features:
- An inner diameter of 0.054 inches with a PTFE liner
- Soft radiopaque tip that facilitates vessel engagement and catheter placement
- Double-stranded steel braid for optimal kink resistance and torque response.
“This is truly an engineering breakthrough,” said James E. Chomas, President and CEO of Surefire Medical. “The nitinol reinforcement enables this device to keep a low 5F profile while providing physicians with maximum support during Surefire procedures, or any other procedures that would require a guide catheter with a large lumen. We are excited to launch this device and continue to demonstrate Surefire’s commitment to the interventional radiology market.”
The Surefire Flexion Guiding Catheter is available in two shapes – the Axis and SIM1. The company continues to offer the Surefire Cobra Guiding Catheter.
About Surefire Medical
Surefire Medical, Inc. develops, manufactures and markets targeted delivery devices for the Interventional Oncology markets. Surefire’s core technology consists of a microcatheter with a unique expandable tip that improves tumor uptake while protecting healthy tissue. It enables physicians to target tumors with superior accuracy, control and protection. Learn more: www.surefiremedical.com.
Media Contact: Jenna Clark Surefire Medical 303.717.2339 [email protected]
